Peter Searle

Willingness to take PhD students

Yes

PhD projects

Dr Searle is interested in supervising doctoral research in the following area:

Gene Therapy of Common Cancers: Immunological and Pharmacological Approaches to Cancer Treatment

View graph of relations

Most downloaded publications

Human Leukocyte Antigen (HLA) A*1101-restricted Epstein-Barr virus-specific T-cell receptor gene transfer to target Nasopharyngeal carcinoma: TCR gene transfer to target NPC
Yong Zheng, Gregory Parsonage, Peter Searle & Steve Lee, 24 Feb 2015, In: Cancer immunology research.

Research output: Contribution to journal › Article › peer-review

110 downloads
E. coli NfsA: an alternative nitroreductase for prodrug activation gene therapy in combination with CB1954
Simon Vass, Eva Hyde & Peter Searle, 16 Jun 2009, In: British Journal of Cancer. 100, 12, p. 1903-11 9 p.

Research output: Contribution to journal › Article › peer-review

90 downloads

Recent publications

Human Leukocyte Antigen (HLA) A*1101-restricted Epstein-Barr virus-specific T-cell receptor gene transfer to target Nasopharyngeal carcinoma: TCR gene transfer to target NPC
Yong Zheng, Gregory Parsonage, Peter Searle & Steve Lee, 24 Feb 2015, In: Cancer immunology research.

Research output: Contribution to journal › Article › peer-review

Long-term proliferation of functional human NK cells, with conversion of CD56(dim) NK cells to a CD56 (bright) phenotype, induced by carcinoma cells co-expressing 4-1BBL and IL-12
Alex Dowell, Steve Lee & Peter Searle, 22 Oct 2011, In: Cancer Immunology Immunotherapy.

Research output: Contribution to journal › Article

Synthesis and structure-activity relationships of nitrobenzyl phosphoramide mustards as nitroreductase-activated prodrugs
Simon Vass, Peter Searle, 1 Jul 2011, In: Bioorganic & Medicinal Chemistry Letters. 21, 13, p. 3986-3991 6 p.

Research output: Contribution to journal › Article › peer-review

View all (42)